Search Results

Viewing Page 3 of 20 | Showing Results 21 - 30 of 198

REDUCE LAP-HF Randomized Trial II

To evaluate the clinical efficacy and safety of the Corvia Medical InterAtrial Shunt Device (IASD® System II) in symptomatic heart failure...

Sameer Gafoor, MD and John Mignone, MD, PhD

The ECLIPSE Trial - Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug- Eluting StEnts

This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions...

John L. Petersen II, MD

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients with Coronary Disease

The primary objective of this trial is to compare the safety and efficacy of the SINOMED BuMA Supreme biodegradable coronary stent in patients with...

John L. Petersen II, MD


To assess the safety and efficacy of the Svelte DES-IDS and the Svelte DES-RX compared to control DES in subjects with ≤ three (3) de novo...

John L. Petersen II, MD

PRELUDE - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study

The purpose of this study is to assess the safety and performance of the Caisson Interventional Transcatheter MitralValve Replacement (TMVR) system...

Ming Zhang, MD, PhD

PIVSD Occluder HDE PAS - The AMPLATZER™ Post-infarct Muscular VSD Occluder HDE Post Approval Study

This is a multi-center, observational study to evaluate the safety and probable benefit of the AMPLATZER™ PIVSD Occluder for use in...

Sameer Gafoor, MD

APOLLO Trial - Transcatheter Mitral Valve Replacement with the Medtronic Intrepid™ TMVR System in patients with severe symptomatic mitral regurgitation

Multi-center, global, prospective, randomized, interventional, pre-market trial with two subject groups: the randomized group will be randomized on...

Co-PIs Sameer Gafoor, MD & Eric Lehr, MD, PhD

AMPLATZER™ PFO Occluder Post Approval Study

The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post...

Sameer Gafoor, MD

A Phase 3 Study in Subjects with Relapsing Remitting Multiple Sclerosis to Evaluate the Tolerability of ALKS 8700 and Dimethyl Fumarate

This study will assess the gastrointestinal (GI) tolerability of ALKS 8700 in adult subjects with RRMS.

James Bowen, MD

Evaluating the Efficacy and Safety of Transitioning Patients from Natalizumab to Ocrelizumab

The primary objective of this study is to assess the efficacy of Ocrelizumab (OCR) in Relapsing Multiple Sclerosis patients who have been...

Pavle Repovic
Viewing Page 3 of 20 | Showing Results 21 - 30 of 198